Article ID Journal Published Year Pages File Type
5622024 Thrombosis Research 2017 5 Pages PDF
Abstract
In the prospective population-based ARIC cohort, β-thromboglobulin was not associated with CVD risk. Our results do not support the hypothesis that a blood marker of higher platelet activity reflects increased future risk of CVD in the general population.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study
Authors
, , ,